Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Injectable preparation of labeled leucine with the carbon 13 for a clinical research program on the Alzheimer disease: pharmaceutical control of raw materials and the finished product and stability study].
Tall ML, Lehmann S, Diouf E, Gérard C, Filali S, Gabelle A, Hirtz C, Gabert L, Sauvinet V, Pirot F, Pivot C. Tall ML, et al. Among authors: pivot c. Ann Pharm Fr. 2015 Jan;73(1):43-59. doi: 10.1016/j.pharma.2014.06.002. Epub 2014 Jul 11. Ann Pharm Fr. 2015. PMID: 25577016 French.
[Aseptic process validation and stability study of an injectable preparation of fructose (5%)-glycerol (10%) as part of a hospital clinical research program on endoscopic curative treatment for early epithelial neoplastic lesions of the gastrointestinal tract].
Tall ML, Salmon D, Diouf E, Drai J, Filali S, Lépilliez V, Pioche M, Laleye D, Dhelens C, Ponchon T, Pivot C, Pirot F. Tall ML, et al. Among authors: pivot c. Ann Pharm Fr. 2015 Mar;73(2):139-49. doi: 10.1016/j.pharma.2014.09.002. Epub 2014 Oct 16. Ann Pharm Fr. 2015. PMID: 25745945 French.
[Injectable hospital preparation of valine labeled with the carbon 13 and nitrogen 15 (5 mg/mL) for a clinical trial on the brain tumor metabolism: Pharmaceutical control of active pharmaceutical ingredient and stability study of the finished product].
Tall ML, Diouf E, Filali S, Sauvinet V, Laleye D, Dhelens C, Salmon D, Gabert L, Nugue G, Sandre-Balester C, Berger F, Pirot F, Pivot C. Tall ML, et al. Among authors: pivot c. Ann Pharm Fr. 2015 Sep;73(5):361-77. doi: 10.1016/j.pharma.2015.02.002. Epub 2015 Mar 5. Ann Pharm Fr. 2015. PMID: 25747724 French.
53 results